Chiesi Wins EU Nod For COPD Triple Combo, But Partner Is Predicted For Launch

 
• By Lucie Ellis-Taitt

Chiesi's triple combination therapy for COPD, Trimbow, has secured its first approval globally after winning a positive recommendation from the CHMP for its use in Europe – but analysts expect a respiratory partner will be required to launch the product.

Three Paper pinwheels isolated on white background
Is three better than two? Chiesi's triple combo COPD therapy to be the first on European market • Source: Shutterstock

More from New Products

More from Scrip